HYTN Innovations Inc (HYTN) AI Stock Analysis

• Market Cap: C$20.91M
• Dividend Yield: N/A
• Average Volume (3M): 15.18K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.66
• Revenue Growth: 27.88%
• EPS Growth: -164.47%
• Country: CA
• Employees: 7
• Sector: Technology
• Sector Strength: 77
• Industry: Beverages - Alcoholic
• EPS (TTM): N/A
• Shares Outstanding: 90,908,090
• 10 Day Avg. Volume: 4,400
• 30 Day Avg. Volume: 15,180
• PEG Ratio: 1.63
• Price to Book (P/B): -137.16
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -16.62
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

HYTN Innovations Inc. shows potential for future growth due to strategic international expansions and partnerships. However, significant financial challenges and negative profitability weigh heavily on its overall score. The stock currently appears overvalued with a negative P/E ratio. Technical indicators are neutral but slightly positive, offering a mixed short-term outlook.

HYTN Innovations Inc Business Overview & Revenue Model

Company Description

HYTN Innovations Inc. engages in the research, production, marketing, distribution, and sale of cannabis products for recreational consumers in Canada. It intends to offer infused sparkling beverages and infused edibles in various flavors. The company is headquartered in Vancouver, Canada.

How the Company Makes Money

HYTN Innovations Inc makes money primarily through the sale of its cannabis-infused beverage products. The company's key revenue streams include direct sales to consumers through retail channels and partnerships with licensed cannabis retailers and distributors. Additionally, HYTN may generate income through strategic partnerships and collaborations with other companies in the cannabis industry, leveraging its expertise in product development and innovation to expand its market presence and reach.

HYTN Innovations Inc Financial Statement Overview

Summary

HYTN Innovations Inc. is struggling with financial instability, evidenced by negative profitability metrics and cash flow challenges. The balance sheet shows negative equity, and reliance on financing activities raises sustainability concerns. Despite some revenue growth, the overall financial health is weak.

Income Statement

HYTN Innovations Inc. has shown some revenue growth, but profitability remains a concern with negative net income, EBIT, and EBITDA margins. The gross profit margin is slightly positive, indicating potential for future improvement, but the net profit margin remains deeply negative.

Balance Sheet

The company's balance sheet shows a negative equity position, indicating financial instability. The debt-to-equity ratio cannot be calculated due to negative equity, and the equity ratio is also negative, highlighting potential solvency issues.

Cash Flow

HYTN's cash flow statement reveals negative free cash flow and operating cash flow, suggesting cash burn. The company relies heavily on financing activities, which may not be sustainable long-term. There is no free cash flow growth, and the ratios to net income are challenging to assess with negative figures.

Breakdown
TTM	Sep 2024	Sep 2023	Sep 2022	Sep 2021	Sep 2019
Income Statement		Total Revenue
849.66K	851.49K	763.46K	696.36K	0.00	0.00
	Gross Profit
50.19K	287.44K	91.85K	121.65K	0.00	-1.12K
	EBIT
-2.86M	-2.69M	-1.67M	-3.04M	-782.19K	-311.69K
	EBITDA
-6.55M	-6.26M	-1.45M	-9.88M	-745.51K	-310.99K
	Net Income Common Stockholders
-6.91M	-6.61M	-2.33M	-17.38M	-959.48K	-311.66K
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
534.43K	256.58K	187.56K	1.03M	264.06K	271.16K
	Total Assets
2.79M	2.38M	2.58M	3.79M	2.76M	507.25K
	Total Debt
804.05K	793.56K	919.74K	887.22K	2.58M	41.98K
	Net Debt
269.62K	536.98K	732.18K	-139.14K	2.31M	-229.18K
	Total Liabilities
2.29M	2.56M	2.27M	1.71M	2.77M	18.41K
	Stockholders Equity
501.41K	-172.97K	314.72K	2.07M	-8.88K	488.85K
Cash Flow		Free Cash Flow
-1.37M	-804.21K	-1.18M	-2.38M	-1.67M	-409.37K
	Operating Cash Flow
-1.36M	-783.36K	-1.18M	-2.16M	-693.52K	-311.08K
	Investing Cash Flow
173.91K	162.67K	-4.10K	2.19M	-1.02M	-98.29K
	Financing Cash Flow
1.16M	689.71K	346.17K	727.93K	1.80M	700.53K

HYTN Innovations Inc Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.21
• 50DMA: Positive
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:HYTN, the sentiment is Positive. The current price of 0.21 is below the 20-day moving average (MA) of 0.22, above the 50-day MA of 0.21, and below the 200-day MA of 0.27, indicating a neutral trend. The MACD of <0.01 indicates Negative momentum. The RSI at 53.11 is Neutral, neither overbought nor oversold. The STOCH value of 27.78 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:HYTN.

HYTN Innovations Inc Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	60 Neutral	$11.59B	10.34	-7.15%	2.94%	7.49%	-10.88%
HYTN	53 Neutral	C$20.91M	―	-9358.55%	―	27.88%	-164.47%
BR	49 Neutral	C$29.30M	―	-46.36%	―	9.98%	-80.44%
LSPK	44 Neutral	C$18.63M	―	-549.30%	―	-8.04%	4.04%

HYTN Innovations Inc Corporate Events

HYTN Innovations Secures GMP Certification for Key International Markets

HYTN Innovations Inc. has received Good Manufacturing Practices (GMP) certificates from Health Canada for its manufacturing facility in Kelowna, confirming compliance for the United States, Bermuda, and Israel. These certifications enhance HYTN’s ability to support drug registrations, facilitate clinical trials, and offer contract manufacturing for cannabis and psilocybin-based pharmaceuticals, positioning the company for international growth and strengthening its leadership in high-quality manufacturing practices.

HYTN Innovations Expands into German Cannabis Market with Strategic Agreements

HYTN Innovations Inc. has secured strategic supply agreements and qualified 4000 kg of cannabis for the German market, marking a significant step in its transition into international pharmaceutical sales. This development strengthens HYTN’s manufacturing capabilities and positions the company for global expansion, particularly in the rapidly growing German medical cannabis sector. The agreements ensure compliance with stringent German pharmacopeia standards and secure a consistent cannabis supply, with initial shipments expected in late Q2 2025.